WO2005049806A3 - Novel nucleic acids and polypeptides - Google Patents

Novel nucleic acids and polypeptides Download PDF

Info

Publication number
WO2005049806A3
WO2005049806A3 PCT/US2004/007412 US2004007412W WO2005049806A3 WO 2005049806 A3 WO2005049806 A3 WO 2005049806A3 US 2004007412 W US2004007412 W US 2004007412W WO 2005049806 A3 WO2005049806 A3 WO 2005049806A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acids
polypeptides
novel nucleic
novel
present
Prior art date
Application number
PCT/US2004/007412
Other languages
French (fr)
Other versions
WO2005049806A2 (en
Inventor
Tom Y Tang
Jian-Rui Wang
Zhi Wei Wang
Jie Zhang
Feiyan Ren
Ping Zhou
Yunqing Ma
Malabika Ghosh
Aidong Xue
Vinod Asundi
Qing Zhao
Dunrui Wang
Ryle Goodrich
Rui-Hong Chen
Tom Wehrman
Gezhi Weng
Bryan Boyle
Original Assignee
Nuvelo Inc
Tom Y Tang
Jian-Rui Wang
Zhi Wei Wang
Jie Zhang
Feiyan Ren
Ping Zhou
Yunqing Ma
Malabika Ghosh
Aidong Xue
Vinod Asundi
Qing Zhao
Dunrui Wang
Ryle Goodrich
Rui-Hong Chen
Tom Wehrman
Gezhi Weng
Bryan Boyle
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nuvelo Inc, Tom Y Tang, Jian-Rui Wang, Zhi Wei Wang, Jie Zhang, Feiyan Ren, Ping Zhou, Yunqing Ma, Malabika Ghosh, Aidong Xue, Vinod Asundi, Qing Zhao, Dunrui Wang, Ryle Goodrich, Rui-Hong Chen, Tom Wehrman, Gezhi Weng, Bryan Boyle filed Critical Nuvelo Inc
Publication of WO2005049806A2 publication Critical patent/WO2005049806A2/en
Publication of WO2005049806A3 publication Critical patent/WO2005049806A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Abstract

The present invention provides nucleic acids, novel polypeptide sequences encoded by these nucleic acids and uses thereof.
PCT/US2004/007412 2003-03-14 2004-03-11 Novel nucleic acids and polypeptides WO2005049806A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38955903A 2003-03-14 2003-03-14
US10/389,559 2003-03-14

Publications (2)

Publication Number Publication Date
WO2005049806A2 WO2005049806A2 (en) 2005-06-02
WO2005049806A3 true WO2005049806A3 (en) 2005-12-29

Family

ID=34619221

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/007412 WO2005049806A2 (en) 2003-03-14 2004-03-11 Novel nucleic acids and polypeptides

Country Status (1)

Country Link
WO (1) WO2005049806A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9399774B2 (en) 2010-04-29 2016-07-26 Ionis Pharmaceuticals, Inc. Modulation of transthyretin expression

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003091402A2 (en) * 2002-04-23 2003-11-06 University Of Georgia Research Foundation, Inc. N-ACETYLGLUCOSAMINYLTRANSFERASE Vb CODING SEQUENCE, RECOMBINANT CELLS AND METHODS
EP1762575A1 (en) * 2005-09-12 2007-03-14 Ganymed Pharmaceuticals AG Identification of tumor-associated antigens for diagnosis and therapy
JP5376948B2 (en) 2005-09-13 2013-12-25 ナショナル リサーチ カウンシル オブ カナダ Methods and compositions for modulating tumor cell activity
GB0613471D0 (en) * 2006-07-06 2006-08-16 Ares Trading Sa Protein
JP5209699B2 (en) * 2007-08-06 2013-06-12 コリア リサーチ インスティテュート オブ バイオサイエンス アンド バイオテクノロジー Gastric cancer gene ZNF312b, protein translated from the gene, diagnostic kit, and anticancer drug screening method using the protein
US8227417B2 (en) 2008-07-25 2012-07-24 The United States Of America As Represented By The Secretary, Department Of Health And Human Services HMGN polypeptides as immune enhancers and HMGN antagonists as immune suppressants
CA2928846A1 (en) 2009-11-24 2011-06-03 Alethia Biotherapeutics Inc. Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume
GB201004551D0 (en) * 2010-03-19 2010-05-05 Immatics Biotechnologies Gmbh NOvel immunotherapy against several tumors including gastrointestinal and gastric cancer
EP3845904A1 (en) * 2010-06-03 2021-07-07 Idexx Laboratories, Inc. Markers for renal disease
BR112014020756A2 (en) 2012-02-22 2017-07-04 Alethia Biotherapeutics Inc co-use of a clusterin inhibitor with an egfr inhibitor to treat cancer

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK [online] 14 January 2002 (2002-01-14), XP002992916, Database accession no. (AF132034) *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9399774B2 (en) 2010-04-29 2016-07-26 Ionis Pharmaceuticals, Inc. Modulation of transthyretin expression

Also Published As

Publication number Publication date
WO2005049806A2 (en) 2005-06-02

Similar Documents

Publication Publication Date Title
WO2004080148A3 (en) Novel nucleic acids and polypeptides
WO2003054152A3 (en) Novel nucleic acids and polypeptides
WO2003025148A3 (en) Novel nucleic acids and polypeptides
WO2002070539A3 (en) Novel nucleic acids and polypeptides
WO2003023013A3 (en) Novel nucleic acids and polypeptides
WO2002081731A3 (en) Novel nucleic acids and polypeptides
WO2001075067A8 (en) Novel nucleic acids and polypeptides
WO2001057188A3 (en) Novel nucleic acids and polypeptides
WO2001057190A3 (en) Novel nucleic acids and polypeptides
WO2002022660A3 (en) Novel nucleic acids and polypeptides
WO2001066689A3 (en) Novel nucleic acids and polypeptides
WO2002031111A3 (en) Novel nucleic acids and polypeptides
WO2001088088A3 (en) Novel nucleic acids and polypeptides
WO2002059260A3 (en) Nucleic acids and polypeptides
WO2004009834A3 (en) Novel nucleic acids and secreted polypeptides
WO2003029271A3 (en) Novel nucleic acids and polypeptides
WO2001053312A8 (en) Novel nucleic acids and polypeptides
WO2001053455A3 (en) Novel nucleic acids and polypeptides
WO2004087874A3 (en) Novel nucleic acids and polypeptides
WO2004074455A3 (en) Fc REGION VARIANTS
WO2002018424A3 (en) Nucleic acids and polypeptides
WO2005047459A3 (en) Sars nucleic acids, proteins, antibodies, and uses thereof
WO2001079449A3 (en) Novel nucleic acids and polypeptides
EP1344827A3 (en) Antifreeze proteins from basidiomycetes
WO2003080795A3 (en) Novel nucleic acids and secreted polypeptides

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase